Furthermore, our team discovered that CLL cells containing the poor prognostic factors del17p or del11q (TP53 and ATM deletions, respectively) are metabolically different compared to CLL cells without these deletions4,5. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.